Related Experiment Video

Updated: Mar 22, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis

Yangyang Wang1, Jiping Zeng2, Jianyong Pan3

  • 1Department of Pharmacology, Shandong University School of Medicine, Jinan 250012, P.R.China.

Oncotarget
|April 19, 2016
PubMed

Insights

MicroRNA-320a (miR-320a) inhibits gastric cancer growth by targeting the FoxM1-P27KIP1 pathway. Lower miR-320a levels correlate with increased tumor progression and reduced P27KIP1 expression in gastric carcinoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are crucial regulators of gene expression involved in tumorigenesis.
  • Gastric cancer is a significant global health concern with complex molecular underpinnings.
  • Understanding novel regulatory pathways is essential for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of miR-320a in gastric cancer.
  • To elucidate the molecular mechanism by which miR-320a affects gastric carcinoma progression.
  • To identify the direct targets and downstream effectors of miR-320a in gastric cancer cells.

Main Methods:

  • Analysis of miR-320a expression in human gastric cancer tissues.
  • Correlation studies between miR-320a, FoxM1, and P27KIP1 expression.
  • Luciferase reporter assays to confirm direct targeting of FoxM1 by miR-320a.
  • In vitro proliferation assays using FoxM1 siRNA.
  • In vivo tumor growth studies in nude mice.

Main Results:

  • miR-320a expression was significantly decreased in gastric cancer tissues.
  • miR-320a directly suppresses FoxM1 expression, a key cell cycle regulator.
  • miR-320a inhibits gastric cancer cell proliferation by modulating the FoxM1-P27KIP1 axis.
  • Suppression of miR-320a in vivo led to accelerated tumor growth.

Conclusions:

  • miR-320a plays a critical tumor-suppressive role in gastric carcinoma.
  • The miR-320a/FoxM1/P27KIP1 axis represents a potential therapeutic target for gastric cancer.
  • Restoring miR-320a levels may offer a novel strategy for gastric cancer treatment.
Keywords:
FoxM1P27KIP1gastric cancermiR-320aproliferation

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K